Alector Inc
Healthcare · EUR · F
Price
€1.868
Cap
€233.15M
Earnings
—
30d Trend
-9.5%
74% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 57×Macro 0.99 (−1%)=56
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 80%
BRAIN47 HORIZON ANALYSIS
6-9 month opportunity — emerging trend
BRAIN47'S ASSESSMENT
I rate Alector Inc at 56/100 — a STRONG reading on the Brain47 Signal. The strongest factor is momentum at 88/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.
PAST PERFORMANCE
1 MONTH
-6.5%
3 MONTHS
-11.5%
12 MONTHS
+51.4%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
6-9 month opportunity — emerging trend. Momentum (88) and Quality (53) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 74%. I classify this as a growth position — strong momentum combined with growth potential points to capital appreciation.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.